Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLD trial of odevixibat after Kasai procedure in biliary atresia
NL-OMON54084Phase 3Recruiting
- Sponsor
- Albireo Pharma
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in biliary atresia comparing Odevixibat with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2021; status: recruiting.
02
Drugs
odevixibat
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NL-OMON54084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54084.